Skip to main content

Table 3 Expression of known Wnt target genes in SFRP1-depleted MDA-MB-468 cells

From: Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling

Name

SEQ_ID

Ratio

TCF7L2

NM_030756

2.37

MMP7

NM_002423

2.28

FN

NM_054034

1.57

CDH1

AB025105

1.37

CDH1

AB025106

1.31

FZD7

BC015915

1.26

VEGF

AY263145

1.2

AXIN2

BC101533

1.19

VEGF

M27281

1.16

CLDN1

BC012471

1.16

VEGF

S85192

1.16

CDH1

NM_004360

1.16

AXIN2

NM_004655

1.13

CLDN1

NM_021101

1.08

JUN

BC006175

1.07

MYC

NM_002467

1.01

BGLAP

NM_199173

0.97

MYCBP

NM_012333

0.95

ID2

NM_002166

0.94

CCND1

NM_053056

0.94

CCND1

BC001501

0.94

PPARD

NM_001039694

0.94

MYCBP

BC008686

0.9

SFRP1

NM_003012

0.28

  1. Only 2 of several known Wnt target genes show increased expression after SFRP1 knockdown (List of genes available from: The Wnt homepage; http://www.stanford.edu/group/nusselab/cgi-bin/wnt/target_genes).